3 Health Insurance Stocks That are Better Buys Than Clover Health

: CLOV | Clover Health Investments Corp. Cl A News, Ratings, and Charts

CLOV – One of the most popular meme stocks this week, Clover Health (CLOV) saw huge gains mid-week as retail traders on Reddit pushed up its price in response to a short squeeze. While CLOV may have a good future ahead of it, Molina Healthcare (MOH), UnitedHealth Group (UNH), and Cigna Corporation (CI) are better buys right now.

As I’ve covered in an article last week, meme stocks have been the talk of the Street this year. This week investors heard quite a lot about Clover Health (CLOV). CLOV is a healthcare technology company that uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. 

In fact, this health insurance technology company was one of the most-discussed stocks on Reddit this week. The stock rose 20% on Tuesday and 9.5% on Wednesday as Reddit traders pushed its value up after talk of the company becoming a target of a short squeeze. Even Chamath Palihapitiya, the venture capitalist behind the company, discouraged traders from buying the stock due to being a short squeeze target.

Retail traders nonetheless kept pushing its price higher. While the company could have a great future ahead of it, I would advise investing in other health insurance stocks, as the volatile nature of CLOV’s price swings may be too high for risk averse investors. Companies such as Molina Healthcare Inc. (MOH), UnitedHealth Group Inc. (UNH), and Cigna Corporation (CI) are more established and rank highly in our proprietary POWR Ratings system.

Molina Healthcare Inc. (MOH)

MOH offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization, or HMO. The company also has a Medicaid Solutions segment that provides solutions to U.S. state governments for their Medicaid management information systems.

The company has seen consistent growth over the past few years. In the first quarter, total revenue soared 43.4% year over year due to increased membership in Medicaid and the Marketplace. MOH has also been gaining from a restructuring and profitability improvement plan that the company started in 2017. The plan has included streamlining its organizational structure to improve efficiency, which has resulted in lower costs.

The company is expected to see continued growth in membership due to contract wins and strategic initiatives. In addition, buyouts, such as YourCare and Magellan Health have extended the company’s capabilities and expanded its geographic diversity. MOH has an overall grade of A and a Strong Buy rating in our POWR Ratings system.

The company had a Value Grade of A, which makes sense as its price to free cash flow ratio of 6.7 is well below the industry average. Plus, the company has an EV/EBITDA under 10. MOH also has a Quality Grade of B due to strong fundamentals. Its return on equity of 33.4% is high and its current ratio of 1.6 indicates the company has more than enough liquidity to handle short-term obligations.

We also provide Growth, Momentum, Stability, and Sentiment grades for MOH, which you can find here. MOH is ranked #1 in the B-rated Medical – Health Insurance industry. For more top stocks in this industry, make sure to visit this link.  

Click here to checkout our Healthcare Sector Report for 2021

UnitedHealth Group Inc. (UNH

UNH is the largest private health insurance provider in the United States, providing medical benefits to 48 million members across its U.S. and international businesses. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, the company has obtained massive scale in managed care. In addition to insurance, its Optum franchises offer everything from medical and pharmaceutical benefits to outpatient care and analytics.

In fact, Optum has become increasingly valuable to the company as it helps diversify its revenue stream. The primary growth catalysts for Optum include its pharmacy care services, care delivery, and government services. It also appears that Optum’s subsegment, OptumInsight, is poised to acquire Change Healthcare, which would help create a more technology-enabled health care platform.

Its government business, consisting of Medicaid and Medicare Advantage, is poised to see massive growth. The upcoming 2021 Medicare enrollment season should help expand its Medicare Advantage footprint as it is expected to reach an additional 3.5 million people in 300 additional counties. Plus, UNH has an overall grade of A, translating into a Strong Buy in our POWR Ratings system.

The company has a Stability Grade of A, indicating it has a history of stable growth and price performance. For instance, earnings have grown an average of 23.1% over the past five years. UNH also has a Sentiment Grade of B, which means it is well-liked by Wall Street analysts. Out of twenty-seven analysts, twenty-four rate the stock a Buy or Strong Buy.

For the rest of UNH’s grades (Growth, Value, Momentum, and Quality), click here

UNH is ranked #2 in the same B-rated industry as MOH (Medical – Health Insurance).

Cigna Corporation (CI)

CI primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense. In its health insurance segment, the company mostly serves employers through self-funding arrangements but also operates in government programs, including Medicare Advantage.

The company’s sales have been rising more than 20% per year consistently over the past ten years. This has been driven by several acquisitions, the company’s operating performance, and its quality products and services. Its bottom line has also been rising over the past few years. Like MOH, CI has been growing its membership base.

This is expected to continue given the company’s wide agent network and superior service, which drives enrollment in commercial market segments. In its Medicare Advantage business, the firm is gaining from product expansion and in-market growth. Plus, its 2018 acquisition of Express Scripts has given the company more tools to help clients control their healthcare costs.

CI has an overall grade of B, translating into a Buy rating in our POWR Ratings system. The company has a Value Grade of B, which isn’t surprising with a trailing P/E of 10.08 and a forward P/E of 11.44. CI also has a Sentiment Grade of B. Similar to UNH, CI is well-liked by the “Smart Crowd.” Twenty-one out of twenty-four analysts rate the stock a Buy or higher.

To gain access to all of CI’s grades, including Growth, Momentum, Stability, and Quality, click here. CI is ranked #3 in the B-rated Medical – Health Insurance industry.

Discover Today’s Best Value Stocks

This article was written by David Cohne, Chief Value Strategist for StockNews.com.  David has helped investors find the most profitable stocks for over 20 years

If you would like to see more of his best value stock ideas, then click the link below.

See David Cohne’s Favorite Value Stocks


CLOV shares were trading at $13.01 per share on Friday afternoon, down $0.78 (-5.66%). Year-to-date, CLOV has declined -22.42%, versus a 14.84% rise in the benchmark S&P 500 index during the same period.


About the Author: David Cohne


David Cohne has 20 years of experience as an investment analyst and writer. Prior to StockNews, David spent eleven years as a consultant providing outsourced investment research and content to financial services companies, hedge funds, and online publications. David enjoys researching and writing about stocks and the markets. He takes a fundamental quantitative approach in evaluating stocks for readers. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CLOVGet RatingGet RatingGet Rating
MOHGet RatingGet RatingGet Rating
UNHGet RatingGet RatingGet Rating
CIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

3 Energy Stocks Set to Soar Beyond Expectations

Given the geopolitical tensions, increasing global oil demand, and supply adjustments, the energy sector is poised for robust growth. Therefore, investors might consider investing in energy stocks TechnipFMC (FTI), Weatherford International (WFRD), and ChampionX (CHX), which are poised to exceed expectations. Keep reading…

Has Carnival (CCL) Stock Turned Into a Buy After Earnings Release?

Carnival Corporation (CCL) reported record revenue in its most recent quarter but still faces a negative bottom line. The collapse of Francis Scott Key Bridge brings more uncertainty to its financials. Given these events, what stance should one take with CCL stock? Read more to find out…

3 China Stocks Positioned for Long-Term Growth

Despite facing challenges, the Chinese economy has demonstrated resilience, as evidenced by recent robust industrial output and retail sales data. Given this outlook, it might be an opportune time to own three top-notch China stocks, JD.com, Inc. (JD), China Automotive Systems (CAAS), and Youdao, Inc. (DAO). Read on…

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More Clover Health Investments Corp. Cl A (CLOV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CLOV News